
==== Front
Jt Dis Relat Surg
Jt Dis Relat Surg
Joint Diseases and Related Surgery
2687-4784
2687-4792
Bayçınar Medical Publishing

10.52312/jdrs.2024.1784
39189572
Original Article
Effects of N-acetylcysteine on sciatic nerve healing: A histopathological, functional, and biochemical study of the rat sciatic nerve
Sarıtaş Tahir Burak http://orcid.org/0009-0001-3049-1723
1
Ertürk Cemil http://orcid.org/0000-0002-9225-917X
2
Büyükdoğan Halil http://orcid.org/0000-0002-0202-444X
3
Yıldırım Burak http://orcid.org/0000-0002-0720-874X
4
Gündüz Nermin http://orcid.org/0000-0003-1237-5486
5
Selek Şahabettin http://orcid.org/0000-0003-1235-3957
6
1 Department of Orthopedics and Traumatology, Tuzla State Hospital, İstanbul, Türkiye
2 Department of Orthopedics and Traumatology, University of Health Sciences, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Türkiye
3 Department of Orthopedics and Traumatology, Beykent University Hospital, İstanbul, Türkiye
4 Department of Orthopedics and Traumatology, Kırklareli Training and Research Hospital, Kırklareli, Türkiye
5 Department of Pathology, University of Health Sciences, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Türkiye
6 Department of Biochemistry, Bezmialem Vakıf University Faculty of Medicine, İstanbul, Türkiye
Tahir Burak Sarıtaş, MD. Tuzla Devlet Hastanesi, Ortopedi ve Travmatoloji Kliniği, 34947 Tuzla, İstanbul, Türkiye. tahirburaksaritas@gmail.com.
9 2024
08 7 2024
35 3 618627
23 4 2024
28 5 2024
Copyright © 2024, Turkish Joint Diseases Foundation
2024
Turkish Joint Diseases Foundation
https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Objectives

This study aims to evaluate the histopathological, biochemical, and functional effects of N-acetylcysteine (NAC), which has antioxidant, anti-inflammatory, and cytoprotective activity, on nerve regeneration in rats with sciatic nerve crush (axonotmesis) injury.

Materials and methods

This study used 16 male Wistar rats, which were divided into treatment and control groups. A standard axonotmesis-type surgical injury was induced in the left sciatic nerves of all rats. The treatment group was given 300 mg/kg of intraperitoneal NAC once a day, whereas the control group received an equal volume of saline solution. After conducting gait analyses, the sciatic functional index (SFI) was used for functional assessment. After gait analysis, all animals were euthanized. Blood samples were examined biochemically. The left sciatic nerves and left triceps surae muscles were examined histopathologically

Results

Histopathologically, the thickness of the perineurium, axonal degeneration, axonolysis, edema, inflammation, muscle atrophy, and muscle degeneration were all significantly lower in the treatment group (p<0.05). Functionally, SFI-1, SFI-2, and SFI-3 were significantly higher in the treatment group (p<0.05). Biochemically, while the native thiol level and native thiol/total thiol ratio were significantly higher in the treatment group (p<0.003), the disulfide/total thiol ratio was significantly higher in the control group (p<0.005). Significant correlations were found between six of the seven gait parameters and the histopathological findings (p<0.05).

Conclusion

Our study results suggest that NAC may contribute positively to the histopathological and functional recovery of sciatic nerve injury in rats. Furthermore, NAC may have an antioxidant effect on thiol-disulfide homeostasis at a biochemical level. We believe that NAC has a stimulatory effect on healing following nerve injuries.

Animal experiment
antioxidant
N-acetylcysteine
sciatic nerve
thiol-disulfide.
==== Body
pmcIntroduction

Peripheral nerve injuries can lead to serious problems. The uncertainties during the healing process have inspired studies aiming to improve healing and nerve regeneration. Preventing oxidative stress after peripheral nerve damage can accelerate the repair process and enhance functional healing following a nerve injury.[1]

N-acetylcysteine (NAC) is primarily used in the treatment of respiratory diseases and hepatotoxicity caused by high doses of paracetamol. It also possesses strong antioxidant and anti-inflammatory properties.[2] The NAC can reduce neuronal death following peripheral nerve injury.[3,4] However, no experimental study has examined the therapeutic effects of NAC on sciatic nerve injuries so far. In the present study, we hypothesized that the antioxidant, anti-inflammatory, and cytoprotective effects of NAC might contribute to sciatic nerve healing. We, therefore, aimed to investigate the effects of NAC on this type of healing in rats.

Patients and Methods

In this study, 16 male Wistar rats weighing between 350 and 500 g and aged between 16 and 18 weeks were used. The rats were given water and standard pellet feed ad libitum and kept in a room under a 12-h light/12-h dark cycle with 50 to 60% humidity and a temperature of 18 to 22°C. The rats were divided into NAC and placebo (control) treatment groups. No information was provided to the experts who evaluated the samples sent for analysis and coding.

Sciatic nerve injury model: Anesthesia and surgical method

All surgical procedures were performed on the rats with inhalation anesthesia in İstanbul Bağcılar Training and Research Hospital Experimental Research and Skills Development Center operating rooms. A standard 2-cm longitudinal skin incision was made along the hip crease line. The biceps femoris muscle was reached after passing through the skin and subcutaneous tissues and blunt dissected along the intermuscular septum. The sciatic nerve was identified directly below and released from soft tissue up to the bifurcation. The sciatic nerve was clamped 1 cm proximal to its bifurcation with a 54-Newton clamp for 30 sec, creating axonotmesis type nerve damage (Figure 1).[5,6] The skin incision was sutured, and a single dose of meloxicam (2 mg/kg) was administered subcutaneously for pain control (Figure 1).[7] These procedures were performed on the same day by the same surgeon. No complications were observed after the procedure in any rat.

Figure 1 Creating damage to the sciatic nerve. (a) Skin incision. (b) Reaching the sciatic nerve. (c) A specialized clamp with a 3 mm wide tip, applying a force of 54 Newtons, and without serrations. (d) Compression of the sciatic nerve with a clamp for 30 seconds. (e) Damaged area in the nerve. (f) Suturation and dressing. (g) Subcutaneous administration of analgesics. (h) Painting the tails of rats according to the work scheme.

N-acetylcysteine administration protocol

Starting from the day of surgery, rats in the treatment group were given 300 mg/kg/day NAC (Mucinac® 300 mg/3 mL ampoule, Vem İlaç, Tekirdağ, Türkiye) via intraperitoneal injection until euthanized.[8] The control rats were given an isosmotic solution of 0.9% NaCl in the same manner (Polifleks®; Polifarma İlaç, Tekirdağ, Türkiye). The rats were injected with appropriate amounts according to their weight, which was measured at intervals.

Euthanasia method, sample preparation, and preservation

Following gait analysis, all animals were euthanized at 30 days after surgery by anesthetic overdose followed by intracardiac blood sampling. The blood samples were centrifuged and transferred to Eppendorf™ tubes (Eppendorf SE: Barkausenweg, Hamburg Germany). The left sciatic nerves of the rats were removed post-euthanasia, from 1 cm distal to 2 cm proximal to the bifurcation. Then, the left triceps surae muscles were dissected to include their proximal and distal attachments. The samples were placed in labeled pathology containers containing a 10% formaldehyde solution.

Histopathological staining and outcome measures

Sciatic nerve and triceps surae muscle samples from each group were placed in 10% formaldehyde and sent to Department of Pathology, Istanbul Kanuni Sultan Süleyman Training and Research Hospital for histopathological examination. For the sciatic nerve samples, the thickness of the perineurium was measured digitally at 1,000× magnification to determine the severity of fibrosis, and the measurements were recorded in µm. The percentages of cells showing axonal degeneration and axonolysis were calculated. Edema was categorized as absent (0-5%), mild (6-30%), or marked (>30%) relative to the histopathology of the intact nerves. Based on the number of inflammatory cells observed, inflammation was categorized as absent (0–1 cell), mild (2-15 cells), or marked (>15 cells). Triceps surae muscle samples were compared based on the histopathology of the healthy side. The atrophy and degeneration of the triceps surae muscle was categorized as absent (0%), mild (1-10%), moderate (11-50%), or severe (>50%).

Biochemical tests and outcome measures

Plasma samples were stored at –80°C until the day of testing. The samples were thawed at room temperature without pretreatment and evaluated using an Architect™ c8000 Clinical Chemistry analyzer (Abbott Diagnostics, Chicago, IL, USA) based on spectrophotometric principles (Figure 2).

Figure 2 The device used for conducting biochemical tests is the “Architech c8000 - Abbott.”

Total and native thiol and disulfide were measured. The direction of change in oxidative/antioxidative status was examined by determining the native thiol/total thiol and disulfide/total thiol ratios of each group.[9,10]

Functional test procedures and outcome measures

Gait was analyzed on postoperative Day 30 using the sciatic functional index (SFI) equations described by Medinaceli (SFI-1), Carlton and Goldberg (SFI-2), and Bain and Maccinon (SFI-3) (Figure 3).[11,12] The footprints of the rats were measured to determine the experimental and normal distances to the opposite foot (ETOF and NTOF, respectively), experimental and normal print lengths (EPL and NPL, respectively), experimental and normal toe spreads (ETS and NTS, respectively), and experimental and normal intermediate toe spreads (EIT and NIT, respectively). Based on these values, the same individual calculated SFI-1, SFI-2, and SFI-3.

Figure 3 (a) Pressing the hind legs of the rat onto the ink pad. (b) A rat walking in a corridor (Sample shot). (c) A rat walking in a hallway (viewed from behind).

Statistical analysis

Statistical analysis was performed using the IBM SPSS version 22.0 software (IBM Corp., Armonk, NY, USA). The normality of the distribution of the parameters was assessed using the Shapiro-Wilk test. Descriptive data were expressed in mean ± standard deviation (SD), median (minmax), or number and frequency, where applicable. Non-normally distributed data were compared using the Mann-Whitney U test. Spearman rho was used to examine relationships between parameters not following a normal distribution. A p value of <0.05 was considered statistically significant.

Results

Histopathological findings

On examining the nerve and muscle histopathology, the treatment group showed significant improvements in all parameters compared to the control group (p<0.05) (Table I). Figures 4-6 depict examples of histopathological staining.

Table 1 Histopathological evaluation findings

 	Control (n=8)	Treatment (n=8)	 	
 	Mean±SD	Median	Min-Max	Mean±SD	Median	Min-Max	p	
Nerve histopathology	 	 	 	 	 	 	 	
The thickness of the perineurium (fibrosis) (μ)	37.13±6.41	36.2	29.4-45.4	27.71 ±7.42	29.5	10.2-33.4	0.012*	
Axonal degeneration (%)	50±7.56	50	40-60	31.25±5.82	30	25-40	0.001*	
Axonolysis (%)	25.63±8.21	25	15-40	12.5±4.63	10	10-20	0.003*	
Edema	1.5±0.53	1.5	1-2	0.25±0.46	0	0-1	0.002*	
Inflammation	1.38±0.74	1.5	0-2	0.13±0.35	0	0-1	0.002*	
Muscle histopathology	 	 	 	 	 	 	 	
Muscle atrophy	1.5±0.53	1.5	1-2	0.5±0.53	0.5	0-1	0.006*	
Muscle degeneration	1.5±0.76	2	0-2	0.63±0.52	1	0-1	0.021*	
SD: Standard deviation; μ: micron; * p<0.05; Mann-Whitney U test.	

Figure 4 Samples of sciatic nerve specimens stained with Hematoxylin-Eosin (H-E). (a) Control group: a section with widespread axonal degeneration (blue arrow), axonolysis (yellow arrow), inflammation (black arrow histiocytes, red arrow mast cells), and significant edema. (b) Treatment group: a section showing axonal degeneration (blue arrow), axonolysis (yellow arrow), inflammation, and mild edema. (c) Typical histomorphology (H-E, ×400).

Figure 5 Sciatic nerve samples stained with MT. (a) Control group: a section with excessive fibrous thickening. (b) Treatment group: less fibrosis in the section compared to the control group. (c) Typical histomorphology (yellow arrow: perineurium thickness) (MT, ×200).<br> MT: Masson's trichrome.

Figure 6 Triceps surae muscle examples with H-E staining. (a) Control group: A section showing moderate signs of atrophy and degeneration. (b) Treatment group: a section showing mild atrophy and degeneration signs. (c) Typical histomorphology (H-E, ×400).

Functional assessment (gait analysis) findings

In the gait assessments, the treatment group had significantly higher scores for all SFIs compared to the controls (p<0.05) (Table II).

Table 2 Functional assessment (gait analysis) findings

 	Control (n=8)	Treatment (n=8)	p	
Mean±SD	Median	Min-Max	Mean±SD	Median	Min-Max	
Gait analysis	 	 	 	 	 	 	 	
Experimental distance to opposite foot	15.46±1.39	15.2	13.5-17.6	15.88±1.37	16.2	13.7-17.4	0.462	
Normal distance to opposite foot	15.99±0.98	15.8	14.9-17.5	15.7±1.18	15.4	14-17.2	0.528	
Experimental print length	3.04±0.38	3.1	2.3-3.5	2.98±0.31	3	2.4-3.4	0.672	
Normal print length	2.64±0.28	2.6	2.2-3	2.83±0.24	2.9	2.4-3.2	0.256	
Experimental toe spread	2.03±0.16	2.1	1.8-2.2	2.25±0.18	2.3	1.9-2.5	0.014*	
Normal toe spread	2.35±0.14	2.4	2.1-2.6	2.28±0.1	2.3	2.1-2.4	0.227	
Experimental intermediate toe spread	1.09±0.11	1.1	0.9-1.2	1.18±0.1	1.2	1.1-1.4	0.202	
Normal intermediate toe spread	1.26±0.07	1.3	1.2-1.4	1.18±0.15	1.2	1-1.4	0.212	
Sciatic functional index-1	-7.8±5.39	-6.5	-17.2 - -0.4	0.27±3.73	-0.1	-4.3-5.5	0.002*	
Sciatic functional index-2	-29.36±9.7	-30.7	-45 - -16.5	-3.89±8.18	-4.3	-13.4-8.3	0.001*	
Sciatic functional index-3	-31.58±5.07	-32.9	-40.5 - -24.3	-11.87±7.68	-12.2	-25.2 - -3.2	0.001*	
SD: Standard deviation; * p<0.05; Mann-Whitney U test.	

Biochemical findings

The treatment group had significantly higher native thiol levels and native thiol/total thiol ratios compared to the controls (p<0.003), while the controls had significantly higher disulfide/total thiol ratios than the treatment group (p<0.005). No significant differences were found for any other parameters (Table III).

Table 3 Biochemical evaluation findings

 	Control (n=8)	Treatment (n=8)	 	
 	Mean±SD	Median	Min-Max	Mean±SD	Median	Min-Max	p	
Biochemical analysis	 	 	 	 	 	 	 	
TTHIOL	394.9±70.15	398.7	292.8-487.8	426.39±66.84	415.5	348.6-554.8	0.600	
NTHIOL	49.46±13.77	47.1	32.1-69.8	88.86±23.69	85.5	45-117.2	0.005*	
Disulfide	345.44±63.32	350.1	252.4-439.6	337.53±54.81	334.2	275-449.2	0.674	
NTHIOL/TTHIOL	0.13±0.03	0.1	0.1-0.2	0.21±0.05	0.2	0.1-0.3	0.003*	
Disulfide /TTHIOL	0.87±0.03	0.9	0.8-0.9	0.79±0.05	0.8	0.7-0.9	0.003*	
SD: Standard deviation; TTHIOL: Total thiol; NTHIOL: Native thiol; * p<0.05; Mann-Whitney U test.	

Compatibility of the histopathological and gait analysis data

Correlation analysis revealed no significant relationship between muscle degeneration and the SFIs. However, significant relationships were found between the SFIs and all other histopathological data (p<0.05) (Table IV).

Table 4 Assessment of the correlation between nerve and muscle histopathology parameters and walking analysis parameters

Gait analysis	Nerve histopathology	Muscle histopathology	
The thickness of the perineurium (fibrosis) (μ)	Axonal degeneration (%)	Axonolysis (%)	Edema	Inflammation	Muscle atrophy	Muscle degeneration	
ETOF	r	0.300	-0.122	0.086	-0.240	0.192	-0.086	-0.200	
p	0.259	0.652	0.751	0.371	0.477	0.751	0.458	
NTOF	r	0.707	0.163	0.440	0.008	0.477	0.029	0.107	
p	0.002*	0.546	0.088	0.977	0.062	0.916	0.693	
EPL	r	0.356	0.182	0.408	0.163	0.468	0.087	-0.169	
p	0.176	0.499	0.117	0.547	0.068	0.749	0.531	
NPL	r	0.097	-0.151	-0.024	-0.278	0.132	-0.277	-0.538	
p	0.721	0.578	0.93	0.298	0.627	0.300	0.032*	
ETS	r	-0.293	-0.538	-0.293	-0.419	-0.407	-0.527	-0.284	
p	0.270	0.031*	0.271	0.106	0.118	0.036*	0.286	
NTS	r	0.464	0.082	0.327	0.262	0.354	0.060	0.259	
p	0.070	0.763	0.216	0.328	0.179	0.825	0.333	
EIT	r	-0.390	-0.376	-0.253	-0.473	-0.388	-0.598	-0.266	
p	0.135	0.152	0.345	0.064	0.137	0.014*	0.319	
NIT	r	0.122	0.006	0.076	0.055	0.172	-0.168	-0.106	
p	0.654	0.982	0.779	0.840	0.525	0.533	0.695	
SFI-1	r	-0.600	-0.536	-0.531	-0.623	-0.614	-0.499	-0.384	
p	0.014*	0.032*	0.034*	0.010*	0.011*	0.049*	0.142	
SFI-2	r	-0.621	-0.603	-0.596	-0.673	-0.697	-0.575	-0.439	
p	0.010*	0.013*	0.015*	0.004*	0.003*	0.020*	0.089	
SFI-3	r	-0.618	-0.594	-0.494	-0.679	-0.671	-0.633	-0.489	
p	0.011*	0.015*	0.055	0.004*	0.004*	0.009*	0.054	
ETOF: Experimental distance to opposite foot; NTOF: Normal distance to opposite foot; EPL: Experimental print length; NPL: Normal print length; ETS: Experimental toe spread; NTS: Normal toe spread; EIT: Experimental intermediate toe spread; NIT: Normal intermediate toe spread; SFI: Sciatic functional index; * p<0.05; Spearman Rho Correlation Analysis.	

Discussion

In this experimental study, we investigated the effects of NAC on this type of healing in rats. Our study has four important findings. First, the treatment group had significantly better results than the control group for all histopathological parameters examined. Second, all SFIs were significantly higher in the treatment group. Third, the treatment group had significantly better antioxidant activity than the control group based on the native thiol, native thiol/total thiol, and disulfide/total thiol values. Finally, a significant correlation was found between histopathological and gait analysis data.

Histopathologically, we observed that NAC contributes to sciatic nerve healing and reduces triceps surae muscle atrophy. Considering the prolonged healing process following peripheral nerve injury, histopathological examinations are crucial for early assessment. In their study investigating sciatic nerve damage following intramuscular injection, Zeynal and Kadıoğlu[13] histopathologically examined fibrosis, Wallerian degeneration, edema, and inflammation parameters in a semi-quantitative manner, similar to Faroni et al.[14] and Sezer et al.[15] Quantitative or semiquantitative methods are commonly used in such studies, although there is no universally accepted method. Therefore, we used quantitative and semi-quantitative histopathological analyses in our study. Somay et al.[16] observed that the ozone molecule, which has antioxidant and anti-inflammatory activity, enhanced rat sciatic nerve healing. Karlidag et al.[17] observed positive effects of NAC on rabbit facial nerve regeneration compared to methylprednisolone. Consistent with the literature, our findings suggest NAC enhances nerve regeneration.

Many studies have focused solely on nerve damage and its treatment, but the main goal of regenerative medicine is to protect muscles and prevent joint contractures. Examining the muscle groups stimulated by a nerve is of importance to assess the quality of end-organ innervation in the context of nerve healing. Mandelbaum-Livnat et al.[18] investigated the effects of laser phototherapy on the healing of rat sciatic nerves and the prevention of muscle atrophy and compared gastrocnemius muscle atrophy between the affected and healthy sides semi-quantitatively. Feng et al.[19] observed that dexamethasone, which has anti-inflammatory properties, had a healing effect on gastrocnemius muscle atrophy after sciatic nerve damage in rats by comparing muscle wet weights between the atrophic and healthy sides. To evaluate the microarchitecture specifically, we semi-quantitatively evaluated muscle atrophy and degeneration by comparing the affected and sides and observed that NAC could reduce the muscle atrophy and muscle degeneration that might develop as a result of nerve damage.

In the current study, we observed a contribution of NAC to functional healing of the sciatic nerve. The rat sciatic nerve model is commonly used for the simultaneous evaluation of motor and sensory nerve function. While the functions of the sciatic nerve in humans can be evaluated through careful motor, sensory, and reflex examinations, this is impossible in rats. Numerous methods have been used to conduct functional analysis of rats. Naik et al.[20] investigated the effect of NAC treatment on rat sciatic nerve recovery and performed behavioral analysis and hyperalgesia, mechanical, and cold allodynia tests, reporting a significant benefit. Walking analysis and SFI are used to evaluate the overall nerve function in rats, since walking involves complex innervation and is a reliable, repeatable, cost-effective, quantitative method for evaluating sciatic nerve healing and function. In SFI evaluations, significant results often emerge after three to four weeks.[19] Therefore, we performed gait analysis and SFI on postoperative Day 30. Our results suggest that NAC has a strong effect on sciatic nerve functional recovery.[21] Some studies have combined SFI with electromyography, and we believe that this enhances functional evaluation.

Biochemically, we observed that NAC had antioxidant effects on thiol-disulfide homeostasis (TDH). Of note, NAC exerts most of its antioxidant effects via intracellular pathways.[22,23] Other studies have investigated the antioxidant effects of NAC on intracellular pathways using tissue samples or cell cultures,[24] while TDH reflects cysteine metabolism and is a system that buffers free oxygen radicals.[9] Recent studies of TDH have revealed its association with several diseases.[25] Therefore, we evaluate TDH using blood samples. While NAC shows antioxidant activity, its correlation with TDH parameters should be investigated to explore its potential use as a biomarker. Future similar studies can be enhanced by using tissue samples and cell culture examinations.

In the present study, we identified a consistent relationship between the histopathological and gait data. Terzis et al.[26] showed that the results of nerve regeneration studies were highly correlated without actually performing a correlation analysis. Based on this, Munro et al.[27] compared functional, electrophysiological, histopathological and histomorphometric parameters and reported that researchers should choose tests according to their study aims. Based on our correlation analysis, we believe that we have confirmed the relationship between the evaluation methods used and the results.

Nonetheless, there are some limitations to our study. Due to ethical concerns, we studied a small number of animals and lacked a sham group. Moreover, our injury model was a standard axonotmesis injury; injuries in humans have different mechanisms. Furthermore, we did not use immunohistochemical methods or electromyography. While we concluded that NAC had a positive effect on nerve regeneration, there is still no evidence regarding the mechanisms involved. In addition, our experiment lasted 30 days, which was too short to provide information about the late stage of regeneration. Finally, while our methods are suitable in rats, they are unlikely to be used in human clinical studies.

In conclusion, we believe that NAC has a healing effect on peripheral nerve injuries. Experimental studies should investigate the potential mechanisms through which NAC affects peripheral nerve regeneration. If future clinical studies support our results, NAC may be considered for use in the treatment of nerve tissue pathologies.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Ethics Committee Approval: The study protocol was approved by the Istanbul Bağcılar Training and Research Hospital Animal Experiments Local Ethics Committee (date: 25.02.2021, no: 2021/41). The study was conducted in accordance with the principles of the Declaration of Helsinki.

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Author Contributions: Idea/concept, design, writing the article: T.B.S., C.E.; Control/supervision, analysis and/or interpretation, critical review: C.E., N.G., Ş.S.; Data collection and/or processing, literature review: T.B.S., H.B., B.Y.; References and fundings: T.B.S., C.E., H.B.; Materials: T.B.S., B.Y., N.G., Ş.S.

Citation: Sarıtaş TB, Ertürk C, Büyükdoğan H, Yıldırım B, Gündüz N, Selek Ş. Effects of N-acetylcysteine on sciatic nerve healing: A histopathological, functional, and biochemical study of the rat sciatic nerve. Jt Dis Relat Surg 2024;35(3):618-627. doi: 10.52312/ jdrs.2024.1784.
==== Refs
1 Qian Y Han Q Zhao X Song J Cheng Y Fang Z 3D melatonin nerve scaffold reduces oxidative stress and inflammation and increases autophagy in peripheral nerve regeneration J Pineal Res 2018 65 e12516 10.1111/jpi.12516
2 Matera MG Calzetta L Cazzola M Oxidation pathway and exacerbations in COPD: The role of NAC Expert Rev Respir Med 2016 10 89 97 10.1586/17476348.2016.1121105 26567752
3 Özdemir M Birinci B Haberal B Ok Atılgan A Demirkale İ In vivo study of the role of hyaluronic acid, N-acetyl cysteine, and deproteinized calf serum on injury-induced cartilage degeneration Jt Dis Relat Surg 2023 34 158 165 10.52312/jdrs.2023.863 36700278
4 Catapano J Zhang J Scholl D Chiang C Gordon T Borschel GH N-acetylcysteine prevents retrograde motor neuron death after neonatal peripheral nerve injury Plast Reconstr Surg 2017 139 1105e-15e 10.1097/PRS.0000000000003257
5 Varejão AS Cabrita AM Meek MF Bulas-Cruz J MeloPinto P Raimondo S Functional and morphological assessment of a standardized rat sciatic nerve crush injury with a non-serrated clamp J Neurotrauma 2004 21 1652 1670 10.1089/neu.2004.21.1652 15684656
6 Ronchi G Nicolino S Raimondo S Tos P Battiston B Papalia I Functional and morphological assessment of a standardized crush injury of the rat median nerve J Neurosci Methods 2009 179 51 57 10.1016/j.jneumeth.2009.01.011 19428511
7 State TO Rodent Anesthesia and Analgesia. Office of Research. Veterinary Guideline 2022. Feb 17;1-6. Available at: https://research.osu.edu/research-responsibilities-andcompliance/animal-care-and-use/animal-care-and-usepolicies-and-2.
8 Ommati MM Amjadinia A Mousavi K Azarpira N Jamshidzadeh A Heidari R N-acetyl cysteine treatment mitigates biomarkers of oxidative stress in different tissues of bile duct ligated rats Stress 2021 24 213 228 10.1080/10253890.2020.1777970 32510264
9 Erel O Neselioglu S A novel and automated assay for thiol/ disulphide homeostasis Clin Biochem 2014 47 326 332 10.1016/j.clinbiochem.2014.09.026 25304913
10 Ertürk C Altay MA Büyükdoğan H Çalışkan G Erel Ö Thiol/disulfide homeostasis as a novel indicator of oxidative stress during the treatment process of patients with septic arthritis Jt Dis Relat Surg 2020 31 502 508 10.5606/ehc.2020.71982 32962582
11 de Medinaceli L Freed WJ Wyatt RJ An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks Exp Neurol 1982 77 634 643 10.1016/0014-4886(82)90234-5 7117467
12 Brown CJ Mackinnon SE Evans PJ Bain JR Makino AP Hunter DA Self-evaluation of walking-track measurement using a Sciatic Function Index Microsurgery 1989 10 226 235 10.1002/micr.1920100317 2796719
13 Zeynal M Kadıoğlu HH All aspects of sciatic nerve injection injury: An experiment with 78 rats Turk J Med Sci 2022 52 1591 1599 10.55730/1300-0144.5499 36422486
14 Faroni A Mobasseri SA Kingham PJ Reid AJ Peripheral nerve regeneration: Experimental strategies and future perspectives Adv Drug Deliv Rev 2015 82-83 160 167 10.1016/j.addr.2014.11.010 25446133
15 Sezer A Guclu B Kazanci B Cakir M Coban MK Neuroprotective effects of agmatine in experimental peripheral nerve injury in rats: A prospective randomized and placebo-controlled trial Turk Neurosurg 2014 24 196 201 10.5137/1019-5149.JTN.7324-12.1 24831360
16 Somay H Emon ST Uslu S Orakdogen M Meric ZC Ince U The histological effects of ozone therapy on sciatic nerve crush injury in rats World Neurosurg 2017 105 702 708 10.1016/j.wneu.2017.05.161 28587982
17 Karlidag T Yildiz M Yalcin S Colakoglu N Kaygusuz I Sapmaz E Evaluation of the effect of methylprednisolone and N-acetylcystein on anastomotic degeneration and regeneraton of the facial nerve Auris Nasus Larynx 2012 39 145 150 10.1016/j.anl.2011.03.004 21601394
18 Mandelbaum-Livnat MM Almog M Nissan M Loeb E Shapira Y Rochkind S Photobiomodulation triple treatment in peripheral nerve injury: Nerve and muscle response Photomed Laser Surg 2016 34 638 645 10.1089/pho.2016.4095 28001757
19 Feng X Yuan W Dexamethasone enhanced functional recovery after sciatic nerve crush injury in rats Biomed Res Int 2015 2015 627923 627923 10.1155/2015/627923 25839037
20 Naik AK Tandan SK Dudhgaonkar SP Jadhav SH Kataria M Prakash VR Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats Eur J Pain 2006 10 573 579 10.1016/j.ejpain.2005.08.006 16214382
21 Atik OŞ Writing for Joint Diseases and Related Surgery (JDRS): There is something new and interesting in this article! Jt Dis Relat Surg 2023 34 533 533 10.52312/jdrs.2023.57916 37750255
22 Schmitt B Vicenzi M Garrel C Denis FM Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study Redox Biol 2015 6 198 205 10.1016/j.redox.2015.07.012 26262996
23 Kumar P Liu C Hsu JW Chacko S Minard C Jahoor F Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial Clin Transl Med 2021 11 e372 10.1002/ctm2.372
24 Senol N Nazıroğlu M Yürüker V N-acetylcysteine and selenium modulate oxidative stress, antioxidant vitamin and cytokine values in traumatic brain injury-induced rats Neurochem Res 2014 39 685 692 10.1007/s11064-014-1255-9 24519543
25 Erel Ö Erdoğan S Thiol-disulfide homeostasis: An integrated approach with biochemical and clinical aspects Turk J Med Sci 2020 50 1728 1738 10.3906/sag-2003-64 32233181
26 Terzis JK Smith KJ Repair of severed peripheral nerves: Comparison of the "de Medinaceli" and standard microsuture methods Exp Neurol 1987 96 672 680 10.1016/0014-4886(87)90228-7 3556204
27 Munro CA Szalai JP Mackinnon SE Midha R Lack of association between outcome measures of nerve regeneration Muscle Nerve 1998 21 1095 1097 10.1002/(sici)1097-4598(199808)21:8<1095::aid-mus20>3.0.co;2-s 9655134
